BRCA1 and BRCA2 mutations in patients with familial breast cancer;Mutaciones en BRCA1 y BRCA2 en pacientes con historia familiar de cáncer de mama

Medicina Clinica

Volumn 124, Issue 1, 2005, Pages 10-12

  Bolufer, Pascual ^a,b   Munárriz, Blanca ^b   Santaballa, Ana ^b   Velasco, Eladio ^c   Lerma, Enrique ^a   Barragán, Eva ^a  

^a Depto de Biopatologia Medica   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

BRCA1; BRCA2; Familial breast cancer; Mutations; Polymorphisms

Indexed keywords

ALLELE; ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER CENTER; CARCINOGENESIS; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA EXTRACTION; FAMILIAL CANCER; FAMILY; FEMALE; GEL ELECTROPHORESIS; GENE; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ONCOGENE; PATIENT SELECTION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SPAIN; UNIVERSITY HOSPITAL;

EID: 13444291192     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13070435     Document Type: Article

References (10)

1. Programa de Consejo Genético en el Cáncer. Grupo de Cancer Hereditario. Plan Oncológico. Comunidad Valenciana. Valencia: Conselleria de Sanitat; 2003
2. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1993;52:678-701.
3. Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, et al. Familial male breast cancer is not linked to BRCA1 locus chromosome 17q. Nat Genet. 1994;7:103-7.
4. Dfez O, Osorio A, Duran M, Martinez-Ferrandis Jl, De la Hoya M, Salazar R, et al. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to spain and evidence of founder effects. Hum Mut. 2003;22:301-12.
5. Velasco Sampedro E, Esteban Cardeñosa E, Infante Sanz M, Durán Domínguez M, Lastra Aras E, Garcia Girón C, et al. Estudío molecular de los genes BRCA1 y BRCA2 en 153 familias con cáncer de mama de Castilla y León (España): identificación de nueve variantes de efecto desconocido no descritas. Med Clin (Barc). 2002;119:441-5.
6. Martínez-Ferrandis JI, Vega A, Chirivella I, Marin-Garcia P, Insa A, Lluch A, et al. Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations. Hum Mutat. 2003;22:417-8.
7. Ganguly A, Rock MJ, Prochop DJ. Conformation sensitive gel electrophoresis for rapid detection of single-base differences in double-standed PCR products and DMA fragmente: evidence for solvent-induced bends in DNA heteroduplex. Proc Natl Acad Sci USA. 1993;90:10325-9.
8. Den Dunnen JT, Antonarakis SE. Mutation nomenclature extension and suggestions to describe complex mutations: a discussion. Human Mutation. 2000;15:7-12.
9. De la Hoya M, Osorio A, Godino J, Sulleiro S, Tosat A, Pérez-Segura P, et al. Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic screening. Int J Cancer. 2002;97:466-71.
10. Fackenthal JD, Cartegni L, Krainer AR, Dlopade OI. BRCA2T2722R is a deleterious allele that causes exon shipping. Am J Hum Genet. 2002;71:625-31.